Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Re: The safety of oral calcium formate.

New Zealand veterinary journal

Scott DJ, Van Wijk N.
PMID: 16032290
N Z Vet J. 2003 Feb;51(1):43. doi: 10.1080/00480169.2003.36330.

A Short Communication was published in the October 2002 issue of the New Zealand Veterinary Journal entitled An investigation of the safety of oral calcium formate in dairy cows using clinical, biochemical and histopathological parameters (McIntyre and Weston 2002)....

Cite
Scott DJ, Van Wijk N. Re: The safety of oral calcium formate. N Z Vet J. 2003;51(1):43doi: 10.1080/00480169.2003.36330.
Scott, D. J., & Van Wijk, N. (2003). Re: The safety of oral calcium formate. New Zealand veterinary journal, 51(1), 43. https://doi.org/10.1080/00480169.2003.36330
Scott, D J, and Van Wijk, N. "Re: The safety of oral calcium formate." New Zealand veterinary journal vol. 51,1 (2003): 43. doi: https://doi.org/10.1080/00480169.2003.36330
Scott DJ, Van Wijk N. Re: The safety of oral calcium formate. N Z Vet J. 2003 Feb;51(1):43. doi: 10.1080/00480169.2003.36330. PMID: 16032290.
Copy Download .nbib Format: NLM
Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin (HbA1c), with continuous glucose monitoring.

Diabetic medicine : a journal of the British Diabetic Association

Barron CV, Heenan HF, Thompson H, Chan H, Ngu J, Lunt H.
PMID: 34957598
Diabet Med. 2021 Dec 27;e14778. doi: 10.1111/dme.14778. Epub 2021 Dec 27.

No abstract available.

Cite
Barron CV, Heenan HF, Thompson H, et al. Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin (HbA1c), with continuous glucose monitoring. Diabet Med. 2021;e14778doi: 10.1111/dme.14778.
Barron, C. V., Heenan, H. F., Thompson, H., Chan, H., Ngu, J., & Lunt, H. (2021). Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin (HbA1c), with continuous glucose monitoring. Diabetic medicine : a journal of the British Diabetic Association, e14778. https://doi.org/10.1111/dme.14778
Barron, Cicely Vm, et al. "Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin (HbA1c), with continuous glucose monitoring." Diabetic medicine : a journal of the British Diabetic Association vol. (2021): e14778. doi: https://doi.org/10.1111/dme.14778
Barron CV, Heenan HF, Thompson H, Chan H, Ngu J, Lunt H. Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin (HbA1c), with continuous glucose monitoring. Diabet Med. 2021 Dec 27;e14778. doi: 10.1111/dme.14778. Epub 2021 Dec 27. PMID: 34957598.
Copy Download .nbib Format: NLM
Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring.

Journal of diabetes and metabolic disorders

de Paula Silva L, de Moraes Rego FG, Picheth G, Müller-Santos M, Alberton D.
PMID: 34222081
J Diabetes Metab Disord. 2021 Mar 29;20(1):611-620. doi: 10.1007/s40200-021-00788-1. eCollection 2021 Jun.

PURPOSE: This prospective study aimed to detect and identify plasma proteins differentially expressed between groups of Brazilian diagnosed with type 1 (T1DM), type 2 (T2DM) diabetes with good and poor glycemic control and the non-diabetic group denominated control group...

Cite
de Paula Silva L, de Moraes Rego FG, Picheth G, et al. Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring. J Diabetes Metab Disord. 2021;20(1):611-620doi: 10.1007/s40200-021-00788-1.
de Paula Silva, L., de Moraes Rego, F. G., Picheth, G., Müller-Santos, M., & Alberton, D. (2021). Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring. Journal of diabetes and metabolic disorders, 20(1), 611-620. https://doi.org/10.1007/s40200-021-00788-1
de Paula Silva, Liliane, et al. "Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring." Journal of diabetes and metabolic disorders vol. 20,1 (2021): 611-620. doi: https://doi.org/10.1007/s40200-021-00788-1
de Paula Silva L, de Moraes Rego FG, Picheth G, Müller-Santos M, Alberton D. Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring. J Diabetes Metab Disord. 2021 Mar 29;20(1):611-620. doi: 10.1007/s40200-021-00788-1. eCollection 2021 Jun. PMID: 34222081; PMCID: PMC8212233.
Copy Download .nbib Format: NLM
The determination of haptoglobins in normal human serum.

The Biochemical journal

Smith H, Owen JA.
PMID: 16748889
Biochem J. 1961 Apr;78(4):723-8. doi: 10.1042/bj0780723.

No abstract available.

Cite
Smith H, Owen JA. The determination of haptoglobins in normal human serum. Biochem J. 1961;78(4):723-8doi: 10.1042/bj0780723.
Smith, H., & Owen, J. A. (1961). The determination of haptoglobins in normal human serum. The Biochemical journal, 78(4), 723-8. https://doi.org/10.1042/bj0780723
Smith, H, and Owen, J A. "The determination of haptoglobins in normal human serum." The Biochemical journal vol. 78,4 (1961): 723-8. doi: https://doi.org/10.1042/bj0780723
Smith H, Owen JA. The determination of haptoglobins in normal human serum. Biochem J. 1961 Apr;78(4):723-8. doi: 10.1042/bj0780723. PMID: 16748889; PMCID: PMC1205460.
Copy Download .nbib Format: NLM
Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report.

Journal of medical case reports

Iacconi P, Giusti L, Da Valle Y, Ciregia F, Giannaccini G, Torregrossa L, Proietti A, Donatini G, Mazzeo S, Basolo F, Lucacchini A.
PMID: 22480342
J Med Case Rep. 2012 Apr 05;6:103. doi: 10.1186/1752-1947-6-103.

INTRODUCTION: Riedel's thyroiditis, a rare thyroid disease, can be difficult to diagnose prior to surgical removal and can be confused with malignancy both clinically and cytologically.CASE PRESENTATION: We report the case of a 72-year-old Caucasian woman who presented with...

Cite
Iacconi P, Giusti L, Da Valle Y, et al. Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. J Med Case Rep. 2012;6:103doi: 10.1186/1752-1947-6-103.
Iacconi, P., Giusti, L., Da Valle, Y., Ciregia, F., Giannaccini, G., Torregrossa, L., Proietti, A., Donatini, G., Mazzeo, S., Basolo, F., & Lucacchini, A. (2012). Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. Journal of medical case reports, 6103. https://doi.org/10.1186/1752-1947-6-103
Iacconi, Pietro, et al. "Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report." Journal of medical case reports vol. 6 (2012): 103. doi: https://doi.org/10.1186/1752-1947-6-103
Iacconi P, Giusti L, Da Valle Y, Ciregia F, Giannaccini G, Torregrossa L, Proietti A, Donatini G, Mazzeo S, Basolo F, Lucacchini A. Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. J Med Case Rep. 2012 Apr 05;6:103. doi: 10.1186/1752-1947-6-103. PMID: 22480342; PMCID: PMC3349472.
Copy Download .nbib Format: NLM
Haptoglobin Hp1 Variant Does Not Associate with Small Vessel Disease.

Brain sciences

Lempiäinen J, Ijäs P, Niiranen TJ, Kaste M, Karhunen PJ, Lindsberg PJ, Erkinjuntti T, Melkas S.
PMID: 31905636
Brain Sci. 2019 Dec 28;10(1). doi: 10.3390/brainsci10010018.

Haptoglobin (Hp) is a plasma protein that binds free hemoglobin and protects tissues from oxidative damage. An Hp2 allele has been associated with an increased risk of cardiovascular complications. On the other hand, recent studies have suggested that Hp1...

Cite
Lempiäinen J, Ijäs P, Niiranen TJ, et al. Haptoglobin Hp1 Variant Does Not Associate with Small Vessel Disease. Brain Sci. 2019;10(1)doi: 10.3390/brainsci10010018.
Lempiäinen, J., Ijäs, P., Niiranen, T. J., Kaste, M., Karhunen, P. J., Lindsberg, P. J., Erkinjuntti, T., & Melkas, S. (2019). Haptoglobin Hp1 Variant Does Not Associate with Small Vessel Disease. Brain sciences, 10(1), . https://doi.org/10.3390/brainsci10010018
Lempiäinen, Juha, et al. "Haptoglobin Hp1 Variant Does Not Associate with Small Vessel Disease." Brain sciences vol. 10,1 (2019). doi: https://doi.org/10.3390/brainsci10010018
Lempiäinen J, Ijäs P, Niiranen TJ, Kaste M, Karhunen PJ, Lindsberg PJ, Erkinjuntti T, Melkas S. Haptoglobin Hp1 Variant Does Not Associate with Small Vessel Disease. Brain Sci. 2019 Dec 28;10(1). doi: 10.3390/brainsci10010018. PMID: 31905636; PMCID: PMC7016682.
Copy Download .nbib Format: NLM
[Not Available].

Diabetologia

Gibb B, Giebelmann R, Martin S, Martin F, Schulz M, Lippmann HG.
PMID: 24173305
Diabetologia. 1966 Apr;1(3):219-27. doi: 10.1007/BF01257915.

The object of this study was that of getting additional insight into the mechanism of proteinuria through analysis of the permeability of the glomerular filter for higher molecular weight proteins in patients with proteinuria resulting from diabetic nephropathy. Fifty...

Cite
Gibb B, Giebelmann R, Martin S, et al. Nachweis von Haptoglobinen und Isoagglutininen im Harn bei diabetischer Angiopathie : Ein Beitrag zur Frage der glomerulären Filtration höhermolekularer Proteine. [Not Available]. Diabetologia. 1966;1(3):219-27doi: 10.1007/BF01257915.
Gibb, B., Giebelmann, R., Martin, S., Martin, F., Schulz, M., & Lippmann, H. G. (1966). Nachweis von Haptoglobinen und Isoagglutininen im Harn bei diabetischer Angiopathie : Ein Beitrag zur Frage der glomerulären Filtration höhermolekularer Proteine. [Not Available]. Diabetologia, 1(3), 219-27. https://doi.org/10.1007/BF01257915
Gibb, B, et al. "Nachweis von Haptoglobinen und Isoagglutininen im Harn bei diabetischer Angiopathie : Ein Beitrag zur Frage der glomerulären Filtration höhermolekularer Proteine." [Not Available]. Diabetologia vol. 1,3 (1966): 219-27. doi: https://doi.org/10.1007/BF01257915
Gibb B, Giebelmann R, Martin S, Martin F, Schulz M, Lippmann HG. Nachweis von Haptoglobinen und Isoagglutininen im Harn bei diabetischer Angiopathie : Ein Beitrag zur Frage der glomerulären Filtration höhermolekularer Proteine. [Not Available]. Diabetologia. 1966 Apr;1(3):219-27. doi: 10.1007/BF01257915. German. PMID: 24173305.
Copy Download .nbib Format: NLM
SERUM HAPTOGLOBINS IN HAEMOLYTIC STATES.

Journal of clinical pathology

Owen JA, de Gruchy GC, Smith H.
PMID: 16810960
J Clin Pathol. 1960 Nov;13(6):478-82. doi: 10.1136/jcp.13.6.478.

Serum haptoglobin levels have been studied in patients with a number of haemolytic disorders. In general, serum haptoglobins were low in patients with increased haemolysis. Values were reduced irrespective of whether haemolysis occurred intravascularly or extravascularly. The reduction was...

Cite
Owen JA, de Gruchy GC, Smith H. SERUM HAPTOGLOBINS IN HAEMOLYTIC STATES. J Clin Pathol. 1960;13(6):478-82doi: 10.1136/jcp.13.6.478.
Owen, J. A., de Gruchy, G. C., & Smith, H. (1960). SERUM HAPTOGLOBINS IN HAEMOLYTIC STATES. Journal of clinical pathology, 13(6), 478-82. https://doi.org/10.1136/jcp.13.6.478
Owen, J A, et al. "SERUM HAPTOGLOBINS IN HAEMOLYTIC STATES." Journal of clinical pathology vol. 13,6 (1960): 478-82. doi: https://doi.org/10.1136/jcp.13.6.478
Owen JA, de Gruchy GC, Smith H. SERUM HAPTOGLOBINS IN HAEMOLYTIC STATES. J Clin Pathol. 1960 Nov;13(6):478-82. doi: 10.1136/jcp.13.6.478. PMID: 16810960; PMCID: PMC480125.
Copy Download .nbib Format: NLM
Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report.

Journal of medical case reports

Iacconi P, Giusti L, Da Valle Y, Ciregia F, Giannaccini G, Torregrossa L, Proietti A, Donatini G, Mazzeo S, Basolo F, Lucacchini A.
PMID: 22480342
J Med Case Rep. 2012 Apr 05;6:103. doi: 10.1186/1752-1947-6-103.

INTRODUCTION: Riedel's thyroiditis, a rare thyroid disease, can be difficult to diagnose prior to surgical removal and can be confused with malignancy both clinically and cytologically.CASE PRESENTATION: We report the case of a 72-year-old Caucasian woman who presented with...

Cite
Iacconi P, Giusti L, Da Valle Y, et al. Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. J Med Case Rep. 2012;6:103doi: 10.1186/1752-1947-6-103.
Iacconi, P., Giusti, L., Da Valle, Y., Ciregia, F., Giannaccini, G., Torregrossa, L., Proietti, A., Donatini, G., Mazzeo, S., Basolo, F., & Lucacchini, A. (2012). Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. Journal of medical case reports, 6103. https://doi.org/10.1186/1752-1947-6-103
Iacconi, Pietro, et al. "Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report." Journal of medical case reports vol. 6 (2012): 103. doi: https://doi.org/10.1186/1752-1947-6-103
Iacconi P, Giusti L, Da Valle Y, Ciregia F, Giannaccini G, Torregrossa L, Proietti A, Donatini G, Mazzeo S, Basolo F, Lucacchini A. Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. J Med Case Rep. 2012 Apr 05;6:103. doi: 10.1186/1752-1947-6-103. PMID: 22480342; PMCID: PMC3349472.
Copy Download .nbib Format: NLM
Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring.

Diabetic medicine : a journal of the British Diabetic Association

Barron CVM, Heenan HF, Thompson H, Chan H, Ngu J, Lunt H.
PMID: 34957598
Diabet Med. 2021 Dec 27;e14778. doi: 10.1111/dme.14778. Epub 2021 Dec 27.

AIMS: Liver cirrhosis increases the risk of developing dysglycaemia (pre-diabetes and diabetes), thus people with cirrhosis should undergo regular screening for dysglycaemia. The utility of screening using the laboratory glycated haemoglobin (HbAMETHODS: Participants ≥18 years with no known diabetes,...

Cite
Barron CVM, Heenan HF, Thompson H, et al. Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring. Diabet Med. 2021;e14778doi: 10.1111/dme.14778.
Barron, C. V. M., Heenan, H. F., Thompson, H., Chan, H., Ngu, J., & Lunt, H. (2021). Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring. Diabetic medicine : a journal of the British Diabetic Association, e14778. https://doi.org/10.1111/dme.14778
Barron, Cicely V M, et al. "Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring." Diabetic medicine : a journal of the British Diabetic Association vol. (2021): e14778. doi: https://doi.org/10.1111/dme.14778
Barron CVM, Heenan HF, Thompson H, Chan H, Ngu J, Lunt H. Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring. Diabet Med. 2021 Dec 27;e14778. doi: 10.1111/dme.14778. Epub 2021 Dec 27. PMID: 34957598.
Copy Download .nbib Format: NLM
Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism.

Glycoconjugate journal

Ito N, Yamada M, Morishita K, Nojima S, Motooka K, Sakata N, Asuka T, Otsu R, Takamatsu S, Kamada Y, Mori S, Akita H, Eguchi H, Morii E, Miyoshi E.
PMID: 33523362
Glycoconj J. 2021 Feb;38(1):45-54. doi: 10.1007/s10719-020-09970-8. Epub 2021 Feb 01.

Fucosylated haptoglobin is a well-established glyco-biomarker of pancreatic cancer. We recently established a novel anti-glycan antibody (10-7G mAb) that specifically recognizes fucosylated haptoglobins, including prohaptoglobin (proHpt). Serum concentrations of the 10-7G value, as measured by ELISA, were increased in...

Cite
Ito N, Yamada M, Morishita K, et al. Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism. Glycoconj J. 2021;38(1):45-54doi: 10.1007/s10719-020-09970-8.
Ito, N., Yamada, M., Morishita, K., Nojima, S., Motooka, K., Sakata, N., Asuka, T., Otsu, R., Takamatsu, S., Kamada, Y., Mori, S., Akita, H., Eguchi, H., Morii, E., & Miyoshi, E. (2021). Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism. Glycoconjugate journal, 38(1), 45-54. https://doi.org/10.1007/s10719-020-09970-8
Ito, Nami, et al. "Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism." Glycoconjugate journal vol. 38,1 (2021): 45-54. doi: https://doi.org/10.1007/s10719-020-09970-8
Ito N, Yamada M, Morishita K, Nojima S, Motooka K, Sakata N, Asuka T, Otsu R, Takamatsu S, Kamada Y, Mori S, Akita H, Eguchi H, Morii E, Miyoshi E. Identification of fucosylated haptoglobin-producing cells in pancreatic cancer tissue and its molecular mechanism. Glycoconj J. 2021 Feb;38(1):45-54. doi: 10.1007/s10719-020-09970-8. Epub 2021 Feb 01. PMID: 33523362.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries